LMNA Human

Lamin A/C Human Recombinant
Cat. No.
BT20811
Source
Escherichia Coli.
Synonyms

Prelamin-A/C, Lamin-A/C, 70 kDa lamin, LMNA, LMN1, Renal carcinoma antigen NY-REN-32, Progerin.

Appearance
Sterile filtered colorless solution.
Purity

Greater than 90.0% as determined by SDS-PAGE.

Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

LMNA Human Recombinant fused with a His tag produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 614 amino acids and having a molecular mass of 68.0kDa. The LMNA is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Lamin-A, a key component of the nuclear lamina, provides structural support to the nucleus. It is encoded by the LMNA gene. The synthesis of Lamin-A involves a precursor molecule, Prelamin A, which undergoes various post-translational modifications. Mutations in the LMNA gene can lead to a group of diseases known as laminopathies. These diseases include Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome.
Description
Recombinant human LMNA, fused with a His tag and produced in E. coli, is a single, non-glycosylated polypeptide chain with a molecular weight of 68.0 kDa, comprising 614 amino acids. Purification is achieved through proprietary chromatographic techniques.
Physical Appearance
Sterile, colorless solution.
Formulation
The LMNA solution is formulated with 20mM Tris-HCl (pH 7.5), 1mM DTT, 0.5M NaCl, 1.5mM EDTA, and 20% (v/v) glycerol.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is greater than 90.0% as determined by SDS-PAGE analysis.
Synonyms

Prelamin-A/C, Lamin-A/C, 70 kDa lamin, LMNA, LMN1, Renal carcinoma antigen NY-REN-32, Progerin.

Source
Escherichia Coli.
Amino Acid Sequence

MAHHHHHHVG TGSNDDDDKS PDMETPSQRR ATRSGAQASS TPLSPTRITR LQEKEDLQEL NDRLAVYIDR VRSLETENAG LRLRITESEE VVSREVSGI KAAYEAELGD ARKTLDSVAK ERARLQLELS KVREEFKELK ARNTKKEGDL IAAQARLKDL EALLNSKEAA LSTALSEKRT LEGELHDLRG QVAKLEAALG EAKKQLQDEM LRRVDAENRL QTMKEELDFQ KNIYSEELRE TKRRHETRLV EIDNGKQREF ESRLADALQE LRAQHEDQVE QYKKELEKTY SAKLDNARQS AERNSNLVGA AHEELQQSRI RIDSLSAQLS QLQKQLAAKE AKLRDLEDSL ARERDTSRRL LAEKEREMAE MRARMQQQLD EYQELLDIKL ALDMEIHAYR KLLEGEEERL RLSPSPTSQR SRGRASSHSS QTQGGGSVTK KRKLESTESR SSFSQHARTS GRVAVEEVDE EGKFVRLRNK SNEDQSMGNW QIKRQNGDDP LLTYRFPPKF TLKAGQVVTI WAAGAGATHS PPTDLVWKAQ NTWGCGNSLR TALINSTGEE VAMRKLVRSV TVVEDDEDED GDDLLHHHHG SHCSSSGDPA EYNLRSRTVL CGTCGQPADK ASASGSGAQS PQNCSIM

Product Science Overview

Introduction

Lamin A/C is a crucial protein found in the nuclear lamina, a dense fibrillar network inside the nucleus of eukaryotic cells. This network provides structural support and regulates various nuclear activities, including DNA replication, transcription, and chromatin organization. Lamin A/C is encoded by the LMNA gene and exists in two main isoforms: lamin A and lamin C, which are produced through alternative splicing.

Structure and Function

Lamin A/C belongs to the type V intermediate filament proteins. These proteins share a conserved tripartite structure consisting of a central α-helical coiled-coil domain flanked by a non-helical N-terminal head and a C-terminal tail domain . The tail domain contains an immunoglobulin (Ig)-fold, which is crucial for the protein’s function .

The primary role of lamin A/C is to provide mechanical support to the nucleus. It also plays a significant role in various nuclear processes, including:

  • DNA replication and repair: Lamin A/C interacts with DNA and other nuclear proteins to facilitate these processes.
  • Gene expression regulation: Lamin A/C is involved in the organization of chromatin, thereby influencing gene expression.
  • Nuclear signaling: Lamin A/C participates in various signaling pathways that regulate cell growth, differentiation, and apoptosis.
Laminopathies

Mutations in the LMNA gene can lead to a group of diseases known as laminopathies. These diseases include muscular dystrophies, lipodystrophies, neuropathies, and premature aging syndromes . The molecular mechanisms by which these mutations cause disease are still not fully understood, but they are believed to disrupt the structural integrity of the nuclear lamina and impair its functions.

Recombinant Lamin A/C

Recombinant lamin A/C is produced using recombinant DNA technology, which involves inserting the LMNA gene into an expression vector and introducing it into a host cell, typically E. coli or yeast. The host cells then produce the lamin A/C protein, which can be purified for research or therapeutic use.

Applications

Recombinant lamin A/C is widely used in research to study the structure and function of the nuclear lamina, as well as the molecular mechanisms underlying laminopathies. It is also used in drug discovery and development, particularly in screening for compounds that can modulate lamin A/C function or expression.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.